Aramark
LSE:0HHB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aramark
LSE:0HHB
|
US |
|
Incannex Healthcare Ltd
F:IQI0
|
AU |
|
T
|
Tidewater Inc
SWB:TD9
|
US |
|
S
|
Seek Ltd
OTC:SKLTY
|
AU |
|
Actinium Pharmaceuticals Inc
F:7AY1
|
US |
|
T
|
Tinna Trade Ltd
BSE:541741
|
IN |
Wall St Price Targets
0HHB Price Targets Summary
Aramark
According to Wall Street analysts, the average 1-year price target for 0HHB is 58.64 USD with a low forecast of 39 USD and a high forecast of 72.85 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0HHB's stock price target?
Price Target
58.64
USD
According to Wall Street analysts, the average 1-year price target for 0HHB is 58.64 USD with a low forecast of 39 USD and a high forecast of 72.85 USD.
What is the Revenue forecast for Aramark?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 6 years is 8%.
What is the Gross Profit forecast for Aramark?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 5 years is 24%.
What is the Operating Income forecast for Aramark?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 6 years is 16%.
What is the Pre-Tax Income forecast for Aramark?
Projected CAGR
36%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 36%.
What is the Net Income forecast for Aramark?
Projected CAGR
23%
Over the last 13 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 6 years is 23%.
